NGM Biopharmaceuticals Inc
NGMDelisted Apr 5, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426332
NGM Biopharmaceuticals Inc was delisted on Apr 5, 2024; its insiders filed their last Form 4 on Apr 8, 2024; 75 institutions reported holding it in 13F filings for Q1 2024, worth $55.1M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding NGM Biopharmaceuticals Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 123 | 106 | −17 |
| Shares | 48.6M | 48.0M | −608.6K (−1.3%) |
| Value | $200.4M | $124.4M | −$76.0M (−37.9%) |
New holders (10)
Institutions that held NGM Biopharmaceuticals Inc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Exchange Traded Concepts, LLC | 39,816 | $103.1K | 0.00% |
| Franklin Resources Inc | 33,438 | $86.6K | 0.00% |
| American Century Companies Inc | 15,738 | $40.8K | 0.00% |
| Arizona State Retirement System | 12,676 | $32.8K | 0.00% |
| Teacher Retirement System of Texas | 12,193 | $32.0K | 0.00% |
| AXA S.A. | 10,500 | $27.2K | 0.00% |
| Prelude Capital Management, LLC | 10,416 | $27.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 7,765 | $20.1K | 0.00% |
| Toronto Dominion Bank | 25 | $0 | 0.00% |
| Simplex Trading, LLC | 136 | $0 | 0.00% |
Sold out (27)
Institutions that held NGM Biopharmaceuticals Inc at the end of Q1 2023 and filed for Q2 2023 without it.